Haw Par Corporation Limited (H02.SI)

SGD 11.09

(-1.25%)

Market Cap (In SGD)

2.45 Billion

Revenue (In SGD)

232.06 Million

Net Income (In SGD)

216.56 Million

Avg. Volume

72.41 Thousand

Currency
SGD
Country
Healthcare
Open
-
Prev. Close
-
Day Range
-
Year Range
9.44-11.52
PE
-
EPS
-
Beta Value
0.373
ISIN
SG1D25001158
CUSIP
381721109
CIK
-
Shares
-
Earnings Annoncement
-

Company Profile

Sector
Healthcare
Industry
Drug Manufacturers - General
CEO
Mr. Ee Lim Wee
Employee Count
-
Website
https://www.hawpar.com
Ipo Date
2000-01-03
Details
Haw Par Corporation Limited, together with its subsidiaries, manufactures, markets, and trades in healthcare products in Singapore, ASEAN countries, other Asian countries, and internationally. The company operates through three segments: Healthcare, Investments, and Others. The Healthcare segment principally manufactures and distributes topical analgesic products under the Tiger Balm and Kwan Loong brand. Its Investments segment invests primarily in quoted securities. In addition, the company owns and leases various investment properties that have lettable area of 45,324 square meters of commercial and industrial space in Singapore and Malaysia. Further, the company provides family and tourist oriented leisure alternatives principally in the form of oceanariums. Haw Par Corporation Limited leases land, building, and office space, as well as offers management support services. The company was incorporated in 1969 and is based in Singapore.